home All News open_in_new Full Article

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to five new non-officer employees consisting of an aggregate of 39,250 share options. All of […]


today 28 h. ago attach_file Other

attach_file Other
attach_file Other
attach_file Science
attach_file Economics
attach_file Events
attach_file Other
attach_file Other
attach_file Other
attach_file Economics
attach_file Transport
attach_file Events
attach_file Economics
attach_file Other
attach_file Economics
attach_file Culture
attach_file Other
attach_file Economics
attach_file Economics
attach_file Events
attach_file Other


ID: 2629654980
Add Watch Country

arrow_drop_down